DAA treatment for hepatitis C among people who inject drugs
The Lancet Gastroenterology & Hepatology in conversation with
English - October 25, 2018 23:00 - 10 minutes - 7.53 MBLife Sciences Science Education gut intestines ibs ibd bowel medicine research Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Pancreatic cancer treatment
Next Episode: Viral hepatitis in migrant populations
Behzad Hajarizadeh joins The Lancet Gastroenterology and Hepatology to discuss his work with direct-acting antiviral treatments for hepatitis C among people inject drugs.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv